For the readers interested in the stock health of Boston Scientific Corporation (BSX). It is currently valued at $39.41. When the transactions were called off in the previous session, Stock hit the highs of $39.48, after setting-off with the price of $39.22. Company’s stock value dipped to $39.10 during the trading on the day. When the trading was stopped its value was $39.34.
Recently in News on March 26, 2021, Boston Scientific Announces Conference Call Discussing First Quarter 2021 Results and Participation in Truist Securities 2021 Life Sciences Summit. Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ending March 31, 2021 on Wednesday, April 28, 2021 at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 28 prior to the conference call. You can read further details here
Boston Scientific Corporation had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $40.13 on 03/09/21, with the lowest value was $34.58 for the same time period, recorded on 01/12/21.
Boston Scientific Corporation (BSX) full year performance was 11.93%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Boston Scientific Corporation shares are logging -6.99% during the 52-week period from high price, and 19.46% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $32.99 and $42.37.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6564638 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Boston Scientific Corporation (BSX) recorded performance in the market was 9.62%, having the revenues showcasing 8.15% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 55.13B, as it employees total of 38000 workers.
The Analysts eye on Boston Scientific Corporation (BSX)
During the last month, 0 analysts gave the Boston Scientific Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 36.86, with a change in the price was noted +1.38. In a similar fashion, Boston Scientific Corporation posted a movement of +3.63% for the period of last 100 days, recording 10,950,103 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BSX is recording 0.60 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.60.
Technical rundown of Boston Scientific Corporation (BSX)
Raw Stochastic average of Boston Scientific Corporation in the period of last 50 days is set at 85.42%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 95.40%. In the last 20 days, the company’s Stochastic %K was 93.17% and its Stochastic %D was recorded 83.61%.
Considering, the past performance of Boston Scientific Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 9.62%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -4.21%, alongside a boost of 11.93% for the period of the last 12 months. The shares increased approximately by 1.18% in the 7-day charts and went down by 1.44% in the period of the last 30 days. Common stock shares were driven by 8.15% during last recorded quarter.